Woodline Partners’s Envoy Medical COCH Stock Holding History

Woodline Partners’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-475,000	Closed	-$4.76M	–	657
2022 Q4	$4.76M	Hold	475,000	–	–	0.06%	325
2022 Q3	$4.67M	Hold	475,000	–	–	0.07%	309
2022 Q2	$4.65M	Hold	475,000	–	–	0.07%	270
2022 Q1	$4.64M	Hold	475,000	–	–	0.08%	252
2021 Q4	$4.63M	Hold	475,000	–	–	0.07%	291
2021 Q3	$4.61M	Hold	475,000	–	–	0.08%	264
2021 Q2	$4.62M	Buy	+475,000	New	+$4.62M	0.09%	232

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Woodline Partners's COCH Position: Q1 2023 in Review

Woodline Partners sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 475,000 shares — an estimated $4.76M sold.

Woodline Partners first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $4.76M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Woodline Partners reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Woodline Partners sold 475,000 Envoy Medical shares in Q1 2023, an estimated $4.76M.
Woodline Partners first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
Woodline Partners's Envoy Medical position peaked at $4.76M in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.